Table 1.
Gene Symbol/Alias | Glomerulus | Tubulointerstitium | Reference | ||||||
---|---|---|---|---|---|---|---|---|---|
| |||||||||
Dataset 1 | Dataset 2 | Dataset 1 | Dataset 2 | ||||||
| |||||||||
Corr. eGFR | DKD vs control | Corr. eGFR | DKD vs control | Corr. eGFR | DKD vs control | Corr. eGFR | DKD vs control | ||
ADIPOQ | −0.08 | 0.89* | 0.60 | 0.97 | 0.23 | 0.97 | 0.01 | 0.87* | 38–41 |
AGT/SERPINA8 | 0.41 | 0.57* | 0.01 | 1.39 | 0.52* | 0.75 | 0.56 | 0.78 | 42–44 |
AMBP/A1M | 0.34 | 0.86 | 0.58 | 1.15 | 0.18 | 0.93 | −0.67* | 0.98 | 42,45,46 |
CCL2 | 0.01 | 3.11* | −0.40 | 1.65 | −0.39 | 1.56* | −0.09 | 3.47* | 41,47–53 |
COL4A1 | −0.36 | 1.74* | −0.53 | 1.07 | −0.64* | 1.95* | −0.21 | 4.41* | 42,54,55 |
CST3/Cystatin C | 0.09 | 1.30* | −0.47 | 1.72 | −0.78* | 1.05 | −0.07 | 1.32 | 42,56–59 |
CTGF/CCN2 | 0.15 | 0.89 | 0.28 | 0.21* | −0.39 | 0.46* | 0.44 | 1.95 | 51,60–62 |
CXCL10/IP10 | 0.46 | 2.01 | −0.01 | 0.97 | −0.51* | 1.13 | −0.34 | 2.13 | 53 |
CXCL8/IL8 | −0.38 | 1.37 | 0.1 | 1.50 | −0.45 | 1.17 | −0.34 | 4.03* | 47,53 |
EGF | 0.81* | 0.33* | 0.10 | 0.42* | 0.73* | 0.37* | 0.83* | 0.19* | 6,7 |
FABP1/L-FABP | 0.52 | 0.24* | 0.37 | 1.02 | 0.51* | 0.55* | 0.45 | 0.51 | 42,63,64 |
FGF23 | −0.43 | 0.88* | −0.29 | 1.04 | −0.19 | 0.92* | −0.46 | 0.92 | 65,66 |
GH1 | −0.25 | 0.91* | 0.18 | 1.09 | −0.17 | 0.93* | −0.35 | 0.9 | 67–69 |
GRN | −0.01 | 1.16* | −0.42 | 1.08 | −0.38 | 1.16* | −0.24 | 1.53* | 70 |
HAVCR1/KIM1 | NA | NA | 0.05 | 1.25* | NA | NA | 0.08 | 1.22 | 65,71–77 |
HIF1A | −0.43 | 1.09 | 0.11 | 1.26 | −0.44 | 1.25* | −0.03 | 1.55* | 78 |
HP | −0.19 | 1.01 | 0.29 | 1.17 | −0.67* | 1.07 | −0.20 | 1.08 | 79,80 |
IFNG | 0.02 | 1.01 | NA | NA | −0.25 | 1.00 | NA | NA | 81,82 |
IGF1 | −0.15 | 0.29* | −0.11 | 0.69 | −0.62* | 0.82* | 0.30 | 0.98 | 78,83 |
IL10 | −0.28 | 1.00 | 0.18 | 1.10 | −0.10 | 0.94 | 0.05 | 0.98 | 47,81 |
IL6 | −0.04 | 1.05 | 0.46 | 0.98 | −0.36 | 0.90 | −0.41 | 1.01 | 47,81 |
KL | 0.36 | 0.42* | −0.02 | 0.89 | 0.33 | 0.59* | 0.72* | 0.42 | 84–88 |
LCN2/NGAL | −0.37 | 1.35 | 0.05 | 1.54* | −0.46 | 1.83* | −0.47 | 2.57* | 42,58,65,72–74,76,78,89–91 |
MMP2 | −0.62* | 2.3* | −0.07 | 1.39* | −0.57* | 1.34* | −0.57 | 1.42 | 69 |
MMP7 | −0.48 | 2.43* | −0.52 | 4.09* | −0.55* | 4.27* | −0.44 | 13.32* | 69,92 |
NAGLU/NAG | 0.71* | 0.98 | 0.73* | 1.13 | 0.58* | 0.78* | 0.41 | 0.71 | 42,74,76,93,94 |
NPHS1 | 0.54 | 0.43* | 0.32 | 0.12* | 0.32 | 0.46* | 0.27 | 0.66* | 42,95,96 |
NPPB | −0.13 | 0.88* | 0.35 | 1.04 | −0.38 | 0.99 | −0.38 | 0.78* | 56,97 |
RBP4 | 0.14 | 0.39* | 0.79* | 0.62 | 0.28 | 0.68 | −0.23 | 0.26* | 49,94,98–100 |
TF | 0.12 | 0.91 | 0.48 | 1.20* | 0.00 | 1.00 | 0.34 | 0.93 | 101 |
TNF | −0.21 | 1.42* | 0.65 | 1.15 | −0.15 | 1.12 | −0.62 | 0.90 | 75,81,102 |
TNFRSF1A/TNFR1 | −0.18 | 1.07 | −0.35 | 1.39* | −0.70* | 0.94 | −0.23 | 1.31* | 72,75,103,104 |
TNFRSF1B/TNFR2 | 0.07 | 2.42* | −0.18 | 1.52* | −0.52* | 1.29* | −0.64* | 1.57* | 75,103–105 |
UMOD | 0.38 | 0.26* | −0.08 | 0.31* | 0.63* | 0.70 | 0.48 | 0.33* | 106,107 |
VCAM1 | −0.31 | 1.67* | −0.48 | 1.37* | −0.59* | 2.00* | 0.12 | 2.64* | 47,108 |
VEGFA/VEGF | 0.43 | 0.64* | 0.35 | 0.38* | 0.70* | 0.64* | 0.67* | 0.60 | 66,78,88 |
VWF | −0.21 | 1.27 | −0.73* | 1.94* | −0.31 | 1.41* | −0.64* | 2.58* | 78,82 |
Gene expression data for both glomeruli and tubulointerstitium were abstracted from two independent published transcriptomic human DKD datasets (see identification below) for candidate biomarkers. Association of gene expression with eGFR was determined as was the relative biomarker expression in DKD vs. normal controls. Shaded areas depict biomarkers in which either (or both) eGFR correlation or gene expression differences were statistically significant in both datasets.
Corr. eGFR: correlation of gene expression with baseline eGFR. NA: data not available.